Table 1.
Characteristics of 61 patients of AAs and CAs
Baseline characteristics | All patients (N = 61) | AAs (N = 31) | CAs (N = 30) | P |
---|---|---|---|---|
Age (years) median (range) | 63 (47–80) | 62 (47–78) | 64 (52–80) | 0.373 |
Gleason sum at postoperative (6–7/8–10) N (%) | 48 (78.7%)/7 (11.5%) | 23 (74.2%)/4 (12.9%) | 25 (83.3%)/3 (10.0%) | 0.705 |
Pathological tumor stage (T2/T3) N (%) | 36 (59.0%)/19 (31.1%) | 18 (58.1%)/9 (29.0%) | 18 (60.0%)/10 (33.3%) | 0.999 |
PSA median (ng/mL) (range) | 6.9 (2.1–214) | 8.4 (3.7–214) | 5.9 (2.1–53.9) | 0.021 |
AAs, African Americans; CA, Caucasian; PSA, Prostate specific antigen.